TipRanks
Go Ultimate55% OFF

Glenmark Pharmaceuticals Limited (GLENMARK) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

GLENMARK Analyst Ratings

There are no analyst ratings in the last 3 months.

GLENMARK Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IN:GLENMARK
Price TargetFollowArticle
ICICI SecuritiesINR 1,640sell-28.94%DownsideReiterated02/03/26
Motilal Oswal Analyst forecast on IN:GLENMARKUnknown AnalystNot RankedMotilal OswalINR 2,240buy-2.95%DownsideReiterated02/02/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Glenmark Pharmaceuticals Limited

3 Months
Abdulkader Puranwala
Abdulkader PuranwalaICICI Securities
Success Rate2/3 ratings generated profit
67%
Average Return
-0.60%

Copying Abdulkader Puranwala's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -0.60% per trade.

1 Year
Abdulkader Puranwala
Abdulkader PuranwalaICICI Securities
Success Rate0/3 ratings generated profit
0%
Average Return
-8.60%

Copying Abdulkader Puranwala's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -8.60% per trade.

2 Years
Abdulkader Puranwala
Abdulkader PuranwalaICICI Securities
Success Rate1/3 ratings generated profit
33%
Average Return
-4.97%

Copying Abdulkader Puranwala's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -4.97% per trade.

GLENMARK Analyst Recommendation Trends

01234Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for GLENMARK
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, GLENMARK has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GLENMARK average Analyst price target in the past 3 months is ―.

GLENMARK Financial Forecast

INR 9INR 12.25INR 15.5INR 18.75INR 22Q3 2026Q1 2027Q2 2027
HighINR 18.10
ConsensusINR 15.60
LowINR 13.00

GLENMARK Earnings Forecast

Next quarter’s earnings estimate for GLENMARK is INR 15.60 with a range of INR 13.00 to INR 18.10. The previous quarter’s EPS was INR 17.11. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

INR 37.7BINR 43.4BINR 49.1BINR 54.8BINR 60.5BQ3 2026Q1 2027Q2 2027
HighINR 42.4B
ConsensusINR 41.1B
LowINR 40.4B

GLENMARK Sales Forecast

Next quarter’s sales forecast for GLENMARK is INR 41.10B with a range of INR 40.42B to INR 42.41B. The previous quarter’s sales results were INR 40.18B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

GLENMARK Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Glenmark Pharmaceuticals Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Glenmark Pharmaceuticals Limited?
To buy shares of IN:GLENMARK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.